Erytech Pharma
(NASDAQ:ERYP)
1.15
00
Last update: 11:20AM
15 minutes delayed
Day High/Low1.01 - 1.16
52 Week High/Low0.98 - 9.5
Open / Close1.15 / -
Float / Outstanding- / 31M
Vol / Avg.4.4K / 915.2K
Mkt Cap35.7M
P/E-
50d Avg. Price1.21
Div / Yield-
Payout Ratio-
EPS-0.38
Total Float-

Erytech Pharma (NASDAQ:ERYP), Quotes and News Summary

Erytech Pharma (NASDAQ: ERYP)

Day High/Low1.01 - 1.16
52 Week High/Low0.98 - 9.5
Open / Close1.15 / -
Float / Outstanding- / 31M
Vol / Avg.4.4K / 915.2K
Mkt Cap35.7M
P/E-
50d Avg. Price1.21
Div / Yield-
Payout Ratio-
EPS-0.38
Total Float-
Benzinga - Apr 27, 2022, 4:27AM
Benzinga - Apr 7, 2022, 8:09AM
load more
Sector: Health Care.Industry: Biotechnology
Erytech Pharma SA is a clinical-stage biopharmaceutical company developing innovative therapies for severe forms of cancer and orphan diseases. Its ERYCAPS platform, uses a novel technology to encapsulate therapeutic drug substances inside erythrocytes, or red blood cells, or RBC. It is developing a pipeline of product candidates for patients with high unmet medical needs. Its lead product candidate eryaspase, also referred as GRASPA, targets the metabolism of cancer cells by depriving the cells of asparagine, an amino acid necessary for their survival and critical in maintaining the cells' rapid growth rate. The company is developing eryaspase for the treatment of severe tumors, including pancreatic cancer, acute lymphoblastic leukemia, or ALL, and triple negative breast cancer, or TNBC.

Earnings

see more
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-09-19
REV
Q1 2022Est.ActualSurprise
EPS
REV

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Erytech Pharma Questions & Answers

Q
How do I buy Erytech Pharma (ERYP) stock?
A

You can purchase shares of Erytech Pharma (NASDAQ: ERYP) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Erytech Pharma's (ERYP) competitors?
Q
What is the target price for Erytech Pharma (ERYP) stock?
A

The latest price target for Erytech Pharma (NASDAQ: ERYP) was reported by JMP Securities on Thursday, September 5, 2019. The analyst firm set a price target for 13.00 expecting ERYP to rise to within 12 months (a possible 1030.43% upside). 0 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Erytech Pharma (ERYP)?
A

The stock price for Erytech Pharma (NASDAQ: ERYP) is $1.15 last updated Today at June 28, 2022, 3:20 PM UTC.

Q
Does Erytech Pharma (ERYP) pay a dividend?
A

There are no upcoming dividends for Erytech Pharma.

Q
When is Erytech Pharma (NASDAQ:ERYP) reporting earnings?
A

Erytech Pharma’s Q2 earnings are confirmed for Monday, September 19, 2022.

Q
Is Erytech Pharma (ERYP) going to split?
A

There is no upcoming split for Erytech Pharma.

Q
What sector and industry does Erytech Pharma (ERYP) operate in?
A

Erytech Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.